1.69
price down icon2.87%   -0.05
after-market アフターアワーズ: 1.76 0.07 +4.14%
loading
前日終値:
$1.74
開ける:
$1.71
24時間の取引高:
179.30K
Relative Volume:
0.85
時価総額:
$111.19M
収益:
$14.18M
当期純損益:
$-82.66M
株価収益率:
-1.30
EPS:
-1.3
ネットキャッシュフロー:
$-50.80M
1週間 パフォーマンス:
-9.14%
1か月 パフォーマンス:
-19.52%
6か月 パフォーマンス:
-14.21%
1年 パフォーマンス:
-11.05%
1日の値動き範囲:
Value
$1.69
$1.755
1週間の範囲:
Value
$1.69
$1.95
52週間の値動き範囲:
Value
$1.56
$2.625

Seer Inc Stock (SEER) Company Profile

Name
名前
Seer Inc
Name
セクター
Healthcare (1164)
Name
電話
650-453-0000
Name
住所
3800 BRIDGE PARKWAY, SUITE 102, REDWOOD CITY
Name
職員
0
Name
Twitter
Name
次回の収益日
2024-11-06
Name
最新のSEC提出書
Name
SEER's Discussions on Twitter

SEER を他の銘柄と比較する

株式 価格 時価総額 収益 当期純利益 現金流量 EPS
Biotechnology icon
SEER
Seer Inc
1.69 111.19M 14.18M -82.66M -50.80M -1.30
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
484.82 131.41B 11.02B -535.60M -978.00M -2.20
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
634.23 72.26B 14.20B 4.41B 3.54B 38.28
Biotechnology icon
ARGX
Argen X Se Adr
591.87 36.10B 2.19B 833.04M -1.28B 12.71
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
270.02 35.03B 2.25B -278.16M -42.59M -2.17
Biotechnology icon
ONC
Beigene Ltd Adr
272.17 28.24B 3.81B -644.79M -669.77M -6.24

Seer Inc Stock (SEER) Upgrades & Downgrades

日付 アクション アナリスト 評価の変更
2023-07-05 再開されました JP Morgan Neutral
2023-01-04 ダウングレード BofA Securities Neutral → Underperform
2022-08-11 ダウングレード JP Morgan Overweight → Neutral
2021-10-15 再開されました Cowen Outperform
2020-12-29 開始されました BofA Securities Neutral
2020-12-29 開始されました Cowen Outperform
2020-12-29 開始されました JP Morgan Overweight
2020-12-29 開始されました Morgan Stanley Equal-Weight
すべてを表示

Seer Inc (SEER) 最新ニュース

pulisher
08:59 AM

SEER LAUNCHES CARBON FOCUSED DIVISION TO PRODUCE LICENSED - GlobeNewswire

08:59 AM
pulisher
08:58 AM

SEER LAUNCHES CARBON FOCUSED DIVISION TO PRODUCE LICENSED BIOCHAR, MONETIZE AND TOKENIZE ASSETS AND CARBON CREDITS AND DEVELOP TURBINE BLADE TREATMENT TECHNOLOGY - Yahoo

08:58 AM
pulisher
Mar 25, 2025

After Plunging -16.59% in 4 Weeks, Here's Why the Trend Might Reverse for Seer (SEER) - Yahoo Finance

Mar 25, 2025
pulisher
Mar 24, 2025

After Plunging -16.81% in 4 Weeks, Here's Why the Trend Might Reverse for Seer (SEER) - Yahoo Finance

Mar 24, 2025
pulisher
Mar 16, 2025

Seer, Inc. (SEER) Reports Q4 Loss, Tops Revenue Estimates - MSN

Mar 16, 2025
pulisher
Mar 10, 2025

Large Tools and Labs Optimistic at TD Cowen Health Conference By Investing.com - Investing.com Australia

Mar 10, 2025
pulisher
Mar 10, 2025

Large Tools and Labs Optimistic at TD Cowen Health Conference - Investing.com India

Mar 10, 2025
pulisher
Mar 10, 2025

Seer Inc (SEER) Q4 2024 Earnings Report Preview: What To Look Fo - GuruFocus.com

Mar 10, 2025
pulisher
Mar 08, 2025

SEER, INC. : Results of Operations and Financial Condition (form 8-K) -January 25, 2021 at 04:40 pm EST - MarketScreener

Mar 08, 2025
pulisher
Mar 06, 2025

Down -10.53% in 4 Weeks, Here's Why Seer (SEER) Looks Ripe for a Turnaround - Yahoo Finance

Mar 06, 2025
pulisher
Mar 06, 2025

Y Intercept Hong Kong Ltd Acquires New Shares in Seer, Inc. (NASDAQ:SEER) - Defense World

Mar 06, 2025
pulisher
Mar 04, 2025

Seer, Inc. Earnings Call: Mixed Sentiment and Optimistic Outlook - TipRanks

Mar 04, 2025
pulisher
Mar 03, 2025

Seer, Inc. SEC 10-K Report - TradingView

Mar 03, 2025
pulisher
Mar 01, 2025

Seer Full Year 2024 Earnings: In Line With Expectations - Yahoo Finance

Mar 01, 2025
pulisher
Feb 28, 2025

Teams at Neptune Beach's Fletcher High win spots at national investment competition - MSN

Feb 28, 2025
pulisher
Feb 28, 2025

Seer, Inc. (NASDAQ:SEER) Q4 2024 Earnings Call Transcript - Insider Monkey

Feb 28, 2025
pulisher
Feb 28, 2025

Seer Inc (SEER) Q4 2024 Earnings Call Highlights: Navigating Rev - GuruFocus.com

Feb 28, 2025
pulisher
Feb 28, 2025

Seer Inc (SEER) Q4 2024 Earnings Call Highlights: Navigating Revenue Decline with Strategic ... - Yahoo Finance

Feb 28, 2025
pulisher
Feb 27, 2025

Seer, Inc. Reports 2024 Earnings and 2025 Outlook - TipRanks

Feb 27, 2025
pulisher
Feb 27, 2025

Seer Inc (SEER) Q4 2024 Earnings: Revenue Beats at $4.0M, EPS Mi - GuruFocus.com

Feb 27, 2025
pulisher
Feb 27, 2025

Seer Inc reports results for the quarter ended December 31Earnings Summary - TradingView

Feb 27, 2025
pulisher
Feb 27, 2025

Earnings call transcript: Seer Inc. reports Q4 2024 revenue decline, stock rises - Investing.com

Feb 27, 2025
pulisher
Feb 27, 2025

Seer Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Full Year 2025 Outlook - The Manila Times

Feb 27, 2025
pulisher
Feb 27, 2025

Can Seer's New Proteomics Application Drive Its Ambitious 24% Revenue Growth Target? - StockTitan

Feb 27, 2025
pulisher
Feb 27, 2025

Seer To Feature Proteomic Advancements in Cancer and RNA Therapy Research Among Other Findings at US HUPO 2025 - Technology Networks

Feb 27, 2025
pulisher
Feb 26, 2025

Seer Inc (SEER) Q4 2024 Earnings Report Preview: What To Look For - Yahoo Finance

Feb 26, 2025
pulisher
Feb 25, 2025

Seer Inc. (SEER) Earnings Preview: Q4 2024 Revenue Expected to Decline 11% - HPBL

Feb 25, 2025
pulisher
Feb 25, 2025

Monash University's Proteomics & Metabolomics Platform Strengthens Partnerships with Seer and Thermo Fisher Scientific - Monash University

Feb 25, 2025
pulisher
Feb 21, 2025

Seer to Participate in the TD Cowen 45th Annual Health Care Conference - GlobeNewswire

Feb 21, 2025
pulisher
Feb 21, 2025

Can Seer's Proteomics Platform Disrupt Healthcare? Management Reveals Strategy Next Week - StockTitan

Feb 21, 2025
pulisher
Feb 21, 2025

Seer (SEER) Expected to Announce Quarterly Earnings on Thursday - Defense World

Feb 21, 2025
pulisher
Feb 20, 2025

Seer to Feature Proteomic Advancements in Cancer and RNA - GlobeNewswire

Feb 20, 2025
pulisher
Feb 20, 2025

US Penny Stocks: 3 Picks With Market Caps As Low As $70M - Simply Wall St

Feb 20, 2025
pulisher
Feb 20, 2025

Seer, Inc. to Showcase Innovations in Proteomics at US HUPO 2025 Annual Conference - Nasdaq

Feb 20, 2025
pulisher
Feb 20, 2025

Revolutionary Cancer Therapy Platform: How Seer's Proteomics Technology is Reshaping Treatment Research - StockTitan

Feb 20, 2025
pulisher
Feb 14, 2025

Peapod Lane Capital LLC Invests $991,000 in Seer, Inc. (NASDAQ:SEER) - MarketBeat

Feb 14, 2025
pulisher
Feb 14, 2025

Seer to Report Fourth Quarter and Full Year 2024 Financial Results on February 27, 2025 - GlobeNewswire

Feb 14, 2025
pulisher
Feb 13, 2025

Seer Proteomics Q4 Earnings Alert: Key Financial Metrics Unveiling February 27 - Stock Titan

Feb 13, 2025
pulisher
Feb 07, 2025

Global X MSCI SuperDividend EAFE ETF (NASDAQ:EFAS) Shares Down 1.1% – What’s Next? - Armenian Reporter

Feb 07, 2025
pulisher
Feb 07, 2025

Omid Farokhzad Sells 8,068 Shares of Seer, Inc. (NASDAQ:SEER) Stock - Armenian Reporter

Feb 07, 2025
pulisher
Feb 07, 2025

Citrine Capital LLC Buys Shares of 24,875 Dimensional U.S. Equity ETF (NYSEARCA:DFUS) - Armenian Reporter

Feb 07, 2025
pulisher
Feb 07, 2025

CSX Co. (NASDAQ:CSX) Shares Acquired by Glassy Mountain Advisors Inc. - Armenian Reporter

Feb 07, 2025
pulisher
Feb 06, 2025

Sompo (OTCMKTS:SMPNY) Reaches New 1-Year High – Should You Buy? - Armenian Reporter

Feb 06, 2025
pulisher
Feb 06, 2025

Illumina (ILMN) Q4 Earnings Miss Estimates - Yahoo Finance

Feb 06, 2025
pulisher
Feb 06, 2025

Seer CEO Omid Farokhzad sells $18,044 in stock - MSN

Feb 06, 2025
pulisher
Feb 06, 2025

Seer Inc.'s president and CFO David Horn sells $7,939 in stock - MSN

Feb 06, 2025
pulisher
Feb 06, 2025

ResMed Inc Director Plans Sale of 2,000 Shares - MSN

Feb 06, 2025
pulisher
Feb 06, 2025

Seer CEO Omid Farokhzad sells $18,044 in stock By Investing.com - Investing.com Nigeria

Feb 06, 2025

Seer Inc (SEER) 財務データ

収益

loading

当期純利益

loading

現金流量

loading

EPS

loading
$70.69
price down icon 1.05%
$76.29
price down icon 2.18%
$31.13
price down icon 0.77%
$19.29
price down icon 5.07%
$91.06
price down icon 4.10%
biotechnology ONC
$272.17
price up icon 1.79%
大文字化:     |  ボリューム (24 時間):